The Company That Makes Remdesivir Says it Considerably Reduces COVID-19 Deaths
https://time.com/5865491/remdesivir-covid-study/
In a report published Friday, researchers from biopharmaceutical company Gilead Sciences said that COVID-19 patients receiving its antiviral drug remdesivir experienced lower mortality rates and better recovery times compared to those not getting the treatment.
The researchers compared 312 people hospitalized for COVID-19 and who received remdesivir to 818 people with similarly severe cases who were treated with standard of care,